American Academy of Pediatrics Recommends Medication to Prevent RSV Be Given to All Infants and Urges Equitable Access - American Academy of Pediatrics

The American Academy of Pediatrics recommends that all infants -- and especially those at high risk --receive the new preventive antibody, nirsevimab, to protect against severe disease caused by respiratory syncytial virus (RSV), which is common, highly conta…